This study is designed to supply L-DOPS (droxidopa) on a long term basis to patients with a
genetic form of profound orthostatic hypotension, most commonly DBH deficiency. It also
allows us to collect medical history information on this small population of patients that
would allow us to determine if there are any complications from this type of treatment.
Details
Lead Sponsor:
Vanderbilt University Vanderbilt University Medical Center